Alucent Biomedical announces FDA approval to proceed with Natural Vascular Scaffolding trial

Alucent Biomedical has received FDA approval to proceed with a phase 1 clinical trial to evaluate the safety and efficacy of its revolutionary Natural Vascular Scaffolding (NVS) technology. The therapy is designed to treat peripheral arterial disease of the lower extremities. The Alucent NVS vessel restoration system with photoactivated linking combines standard angioplasty with [...]